TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/7/21 08:25 | 9/3/21 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Johnson Wendy S. | CA | D | P | 14 | 14.02 | 0 | 1 | New | 1 | D | |||||||||||||||
7/15/21 17:33 | 7/14/21 | RPHM | Reneo Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson Wendy S. | CA | O | Chief De | S | -950 | 8.50 | 0 | -112 | -100 | 0 | D | ||||||||||||||
7/9/21 18:52 | 7/8/21 | RPHM | Reneo Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson Wendy S. | CA | O | Chief De | M.d | 220 | 1.97 | 0 | 112 | New | 112 | D | ||||||||||||||
10/7/15 14:50 | 10/5/15 | APHB | Ampliphi Biosciences Corp | WA | Health | BioPrd | Biological Products, (No Diag | Johnson Wendy S. | VA | DO | Interim | P | 4 | 4.43 | 0 | 1 | New | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |